Skip to main content

The Evolving Patent Eligibility of Life Sciences Method Claims

Speaker(s): Brian A. Cocca, Ph.D., Donald L. Zuhn, Jr., Ph.D., June E. Cohan, Sarah E. Fendrick, Ph.D.
Recorded on: Sep. 9, 2019
PLI Program #: 283253

Donald L. Zuhn, Jr., Ph.D., is a partner at McDonnell Boehnen Hulbert & Berghoff LLP, where his practice focuses on biotechnology and pharmaceutical patent prosecution, litigation, counseling, and licensing.  He received his Ph.D. from the University of Illinois at Chicago, and graduated summa cum laude from the John Marshall Law School, where he helped found the John Marshall Review of Intellectual Property Law.  Dr. Zuhn is also the editor and co-founder of the Patent Docs weblog (, which focuses on developments in patent law, and which has been named to the American Bar Association's "Blawg 100," recognizing the 100 best legal blogs.

I am an intellectual property attorney with extensive experience in the private and public sectors. Prior to joining the USPTO, my practice included litigation of patent infringement and Section 337 actions in the federal courts and before the U.S. International Trade Commission, as well as patent and trademark prosecution, opinions, and client counseling in the biotechnology, pharmaceutical, and software areas. I am a frequent public speaker, and have authored legal publications on topics including licensing, patent validity, intellectual property litigation and administrative proceedings, encryption regulation and copyright law. I also teach advanced patent law and intellectual property courses at local universities as an adjunct professor.

Sarah E. Fendrick is a partner with McDonnell Boehnen Hulbert & Berghoff LLP. Dr. Fendrick’s practice comprises patent procurement, patent enforcement, and interference practice in the biotechnology field including therapeutic antibodies, stem cells, diagnostics, pharmaceuticals, peptide therapeutics, vaccines, metabolomics and biofuels.